A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis.
To create a database of information regarding Tranthyretin amyloidosis in order to better understand the disease and its natural history, and improve the care of patients by using the information gathered to develop new treatments and guidlines.
Must be at least 18 years of age, and have confirmed TTR mutation or TTR amyloidosis. May not be in a current investigational clinical trial or receiving an investigational drug and/or device, or have primary or secondary amyloidosis.
18 - 100
Healthy Volunteers Needed
Duration of Participation
This is an ongoing survery that will last at least 10 years.